Unknown

Dataset Information

0

Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling.


ABSTRACT: Interleukin-6 (IL-6) is a critical regulator of the immune system and has been widely implicated in autoimmune disease. Here, we describe the discovery and characterization of olokizumab, a humanized antibody to IL-6. Data from structural biology, cell biology and primate pharmacology demonstrate the therapeutic potential of targeting IL-6 at "Site 3", blocking the interaction with the signaling co-receptor gp130.

SUBMITTER: Shaw S 

PROVIDER: S-EPMC4011921 | biostudies-literature | 2014 May-Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling.

Shaw Stevan S   Bourne Tim T   Bourne Tim T   Meier Chris C   Carrington Bruce B   Gelinas Rich R   Henry Alistair A   Popplewell Andrew A   Adams Ralph R   Baker Terry T   Rapecki Steve S   Marshall Diane D   Moore Adrian A   Neale Helen H   Lawson Alastair A  

mAbs 20140402 3


Interleukin-6 (IL-6) is a critical regulator of the immune system and has been widely implicated in autoimmune disease. Here, we describe the discovery and characterization of olokizumab, a humanized antibody to IL-6. Data from structural biology, cell biology and primate pharmacology demonstrate the therapeutic potential of targeting IL-6 at "Site 3", blocking the interaction with the signaling co-receptor gp130. ...[more]

Similar Datasets

| S-EPMC5382562 | biostudies-literature
| S-EPMC8371079 | biostudies-literature
| S-EPMC4846058 | biostudies-literature
| S-EPMC4650419 | biostudies-literature
| S-EPMC7671035 | biostudies-literature
| S-EPMC4007646 | biostudies-literature
| S-EPMC4640888 | biostudies-literature
| S-EPMC298637 | biostudies-other
| S-EPMC5983313 | biostudies-literature
| S-EPMC5923367 | biostudies-literature